Thierry Langer

Orcid: 0000-0002-5242-1240

According to our database1, Thierry Langer authored at least 35 papers between 1993 and 2024.

Collaborative distances:
  • Dijkstra number2 of five.
  • Erdős number3 of four.

Timeline

Legend:

Book 
In proceedings 
Article 
PhD thesis 
Dataset
Other 

Links

Online presence:

On csauthors.net:

Bibliography

2024
Active Learning Approach for Guiding Site-of-Metabolism Measurement and Annotation.
J. Chem. Inf. Model., 2024

2023
High-Quality Conformer Generation with CONFORGE: Algorithm and Performance Assessment.
J. Chem. Inf. Model., September, 2023

Identification of Promising Sulfonamide Chalcones as Inhibitors of SARS-CoV-2 3CL<sup>pro</sup> through Structure-Based Virtual Screening and Experimental Approaches.
J. Chem. Inf. Model., August, 2023

<i>Apo2ph4</i>: A Versatile Workflow for the Generation of Receptor-based Pharmacophore Models for Virtual Screening.
J. Chem. Inf. Model., 2023

2021
QPHAR: quantitative pharmacophore activity relationship: method and validation.
J. Cheminformatics, 2021

2019
LigandScout Remote: A New User-Friendly Interface for HPC and Cloud Resources.
J. Chem. Inf. Model., 2019

2018
SAR-Guided Scoring Function and Mutational Validation Reveal the Binding Mode of CGS-8216 at the α1+/γ2- Benzodiazepine Site.
J. Chem. Inf. Model., 2018

2017
Common Hits Approach: Combining Pharmacophore Modeling and Molecular Dynamics Simulations.
J. Chem. Inf. Model., 2017

2012
Recognizing Pitfalls in Virtual Screening: A Critical Review.
J. Chem. Inf. Model., 2012

2009
Hydrogen-Bonding Patterns of Minor Groove-Binder-DNA Complexes Reveal Criteria for Discovery of New Scaffolds.
J. Chem. Inf. Model., 2009

2008
Discovery of Novel Cathepsin S Inhibitors by Pharmacophore-Based Virtual High-Throughput Screening.
J. Chem. Inf. Model., 2008

Evaluation of the performance of 3D virtual screening protocols: RMSD comparisons, enrichment assessments, and decoy selection - What can we learn from earlier mistakes?
J. Comput. Aided Mol. Des., 2008

2007
Parallel Screening and Activity Profiling with HIV Protease Inhibitor Pharmacophore Models.
J. Chem. Inf. Model., 2007

DNA Minor Groove Pharmacophores Describing Sequence Specific Properties.
J. Chem. Inf. Model., 2007

Fast and Efficient in Silico 3D Screening: Toward Maximum Computational Efficiency of Pharmacophore-Based and Shape-Based Approaches.
J. Chem. Inf. Model., 2007

Generation of a homology model of the human histamine H<sub>3</sub> receptor for ligand docking and pharmacophore-based screening.
J. Comput. Aided Mol. Des., 2007

Pharmacophore modeling and parallel screening for PPAR ligands.
J. Comput. Aided Mol. Des., 2007

2006
Parallel Screening: A Novel Concept in Pharmacophore Modeling and Virtual Screening.
J. Chem. Inf. Model., 2006

Pharmacophore Modeling and in Silico Screening for New P450 19 (Aromatase) Inhibitors.
J. Chem. Inf. Model., 2006

Structure-Based Pharmacophore Design and Virtual Screening for Novel Angiotensin Converting Enzyme 2 Inhibitors.
J. Chem. Inf. Model., 2006

Comparative Performance Assessment of the Conformational Model Generators Omega and Catalyst: A Large-Scale Survey on the Retrieval of Protein-Bound Ligand Conformations.
J. Chem. Inf. Model., 2006

Influence of the Conditions in Pharmacophore Generation, Scoring, and 3D Database Search for Chemical Feature-Based Pharmacophore Models: One Application Study of ET<sub>A</sub>- and ET<sub>B</sub>-Selective Antagonists.
J. Chem. Inf. Model., 2006

Efficient overlay of small organic molecules using 3D pharmacophores.
J. Comput. Aided Mol. Des., 2006

High-throughput structure-based pharmacophore modelling as a basis for successful parallel virtual screening.
J. Comput. Aided Mol. Des., 2006

GBPM: GRID-based pharmacophore model: concept and application studies to protein-protein recognition.
Bioinform., 2006

2005
LigandScout: 3-D Pharmacophores Derived from Protein-Bound Ligands and Their Use as Virtual Screening Filters.
J. Chem. Inf. Model., 2005

Human Rhinovirus 3C Protease: Generation of Pharmacophore Models for Peptidic and Nonpeptidic Inhibitors and Their Application in Virtual Screening.
J. Chem. Inf. Model., 2005

The Identification of Ligand Features Essential for PXR Activation by Pharmacophore Modeling.
J. Chem. Inf. Model., 2005

Pharmacophore Identification, in Silico Screening, and Virtual Library Design for Inhibitors of the Human Factor Xa.
J. Chem. Inf. Model., 2005

Comparative Analysis of Protein-Bound Ligand Conformations with Respect to Catalyst's Conformational Space Subsampling Algorithms.
J. Chem. Inf. Model., 2005

2004
Influenza Virus Neuraminidase Inhibitors: Generation and Comparison of Structure-Based and Common Feature Pharmacophore Hypotheses and Their Application in Virtual Screening.
J. Chem. Inf. Model., 2004

Combining Ethnopharmacology and Virtual Screening for Lead Structure Discovery: COX-Inhibitors as Application Example.
J. Chem. Inf. Model., 2004

Impact of Scoring Functions on Enrichment in Docking-Based Virtual Screening: An Application Study on Renin Inhibitors.
J. Chem. Inf. Model., 2004

1998
On the Use of Chemical Function-Based Alignments as Input for 3D-QSAR.
J. Chem. Inf. Comput. Sci., 1998

1993
Inhibitors of prolyl endopeptidase: Characterization of the pharmacophoric pattern using conformational analysis and 3D-QSAR.
J. Comput. Aided Mol. Des., 1993


  Loading...